A comparison of the inhibitory effects of certain antiparkinsonian agents on dopamine accumulation into the rat striatum.
D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology; D000978:Antiparkinson Agents / Q000494:pharmacology*; D001285:Atropine / Q000494:pharmacology; D001590:Benztropine / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism*; D004155:Diphenhydramine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism*; D006016:Glycolates / Q000494:pharmacology; D008297:Male; D008928:Mitochondria / Q000378:metabolism; D010042:Ouabain / Q000494:pharmacology; D010640:Phenothiazines / Q000494:pharmacology; D051381:Rats; D014282:Trihexyphenidyl / Q000494:pharmacology
D000928:Antidepressive Agents; D000978:Antiparkinson Agents; D006016:Glycolates; D010640:Phenothiazines; D001590:Benztropine; D010042:Ouabain; D014282:Trihexyphenidyl; D001285:Atropine; D004155:Diphenhydramine; D002746:Chlorpromazine; D004298:Dopamine